Assessment of the Interleukin-32 and Interleukin-35 Levels in the Circulation of Hashimoto’s Thyroiditis Patients
Medical Journal of Babylon · 2026-04 · 23 (2) · 1524-1527
DOI: 10.4103/mjbl.mjbl_186_24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Journal of Babylon, online erschienen am 18.08.2026. Verfasst von Ahmed Hadi Saeed Al-Khafaji und 2 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Hashimoto’s thyroiditis (HT) is a more common autoimmune disease causing chronic thyroid gland inflammation with many genetic and environmental uncertain etiologies. The main characteristic of HT is the loss of thyroid tissue as a result of a strong immune response against thyroid self-antigens, which promotes autoantibody formation and cytokine production, resulting in local inflammation and immune cell infiltration.
Objectives
The current study aimed to investigate the levels of interleukin-32 (IL-32) and interleukin-35 (IL-35), as well as their correlation with Hashimoto’s thyroiditis. Materials and Methods: One hundred twenty subjects were enrolled in this study. The study included 60 individuals diagnosed with HT and 60 healthy individuals, ages ranging from 20 to 64 years, with the latter group having no known diseases or history of drug use. The study groups were subjected to serological investigation of IL-32, IL-35, anti-thyroid peroxidase antibody (anti-TPO Ab), anti-thyroglobulin antibody (anti-Tg Ab), thyroid stimulating hormone (TSH), FT3, and FT4 using ELISA and VIDAS techniques.
Results
Regarding the IL-32 level, the results in patients with HT were significantly ( P < 0.001) increased in comparison to the control group. Significant difference was determined between the groups in terms of the IL-35 levels ( P value < 0.001), which were lower than the control.
Conclusion
The cytokines IL-32 and IL-35 may be regarded as possible biomarkers for Hashimoto’s thyroiditis, and their levels may be utilized as a follow-up measurement and may provide novel targets for Hashimoto’s thyroiditis therapy in the future.
Zitieren
APA
Al-Khafaji, A. H. S., Al-Khafaj, J. K. T., & Abid, A. J. (2026). Assessment of the Interleukin-32 and Interleukin-35 Levels in the Circulation of Hashimoto’s Thyroiditis Patients. Medical Journal of Babylon, 23(2), 1524-1527. https://doi.org/10.4103/mjbl.mjbl_186_24
Vancouver
Al-Khafaji AHS, Al-Khafaj JKT, Abid AJ. Assessment of the Interleukin-32 and Interleukin-35 Levels in the Circulation of Hashimoto’s Thyroiditis Patients. Medical Journal of Babylon. 2026;23(2):1524-1527. doi:10.4103/mjbl.mjbl_186_24
BibTeX
@article{AlKhafaji2026,
author = {Al-Khafaji, Ahmed Hadi Saeed and Al-Khafaj, Jawad Kadhim Tarrad and Abid, Abdulnabi J.},
title = {Assessment of the Interleukin-32 and Interleukin-35 Levels in the Circulation of Hashimoto’s Thyroiditis Patients},
journal = {Medical Journal of Babylon},
year = {2026},
volume = {23},
number = {2},
pages = {1524--1527},
doi = {10.4103/mjbl.mjbl_186_24}
}
EUVIMED